← Back to Search

Positive Parenting Techniques for Depression (ADAPT Trial)

N/A
Recruiting
Led By Brendan F Andrade, Ph.D.
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Parent cannot communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is to study a novel targeted treatment for depressed parents of children with emotional and behavioural difficulties (EBD). The aim is to see if the treatment is feasible and acceptable, and if the parents stick to the study protocol.

Who is the study for?
This trial is for parents over 18 with children aged 6-10 who have significant emotional or behavioral difficulties. Parents must be able to participate in group therapy, speak English, and not have severe mental health issues like active suicidal thoughts or substance abuse. Children with Autism Spectrum Disorder or Intellectual Disability are excluded.
What is being tested?
The ADAPT program aims to help parents of children with emotional and behavioral difficulties by addressing parental depression and teaching positive parenting techniques. The study will assess the feasibility, acceptability, and adherence to this novel treatment approach.
What are the potential side effects?
Since this intervention involves psychological therapy rather than medication, side effects may include discomfort from discussing personal issues in a group setting but are generally considered low-risk compared to drug treatments.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My parent cannot speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinician adherence to ADAPT protocol measured by fidelity checks
Percentage of treatment sessions attended by parents measured using weekly attendance log
Treatment acceptability/satisfaction measured by weekly evaluation forms filled out by parents

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Parent Group TreatmentExperimental Treatment1 Intervention
Families who meet inclusion criteria will participate in the Parent Group Treatment (ADAPT Program).
Group II: No TreatmentActive Control1 Intervention
Families who do not meet inclusion criteria will not be invited to participate in the ADAPT Program.

Find a Location

Who is running the clinical trial?

Women's College HospitalOTHER
106 Previous Clinical Trials
43,481 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
372 Previous Clinical Trials
82,755 Total Patients Enrolled
5 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
431 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Brendan F Andrade, Ph.D.Principal InvestigatorCentre for Addiction and Mental Health
1 Previous Clinical Trials
172 Total Patients Enrolled

Media Library

Addressing Depression and Positive Parenting Techniques (ADAPT) Program Clinical Trial Eligibility Overview. Trial Name: NCT04298437 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Parent Group Treatment, No Treatment
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Addressing Depression and Positive Parenting Techniques (ADAPT) Program Highlights & Side Effects. Trial Name: NCT04298437 — N/A
Addressing Depression and Positive Parenting Techniques (ADAPT) Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04298437 — N/A
~22 spots leftby Dec 2025